Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | October 11, 2022 05:57pm

Gainers

  • Adamis Pharmaceuticals (NASDAQ:ADMP) stock rose 41.7% to $0.21 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.8 million shares, which is 219.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
  • OpGen (NASDAQ:OPGN) shares moved upwards by 18.26% to $0.25. The market value of their outstanding shares is at $13.2 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) stock rose 11.98% to $8.41. The company's market cap stands at $7.7 million.
  • InVivo Therapeutics Hldg (NASDAQ:NVIV) shares rose 11.34% to $3.73. The company's market cap stands at $5.1 million.
  • SCWorx (NASDAQ:WORX) stock rose 10.05% to $0.76. The company's market cap stands at $9.7 million.
  • Applied Genetic Techs (NASDAQ:AGTC) shares rose 9.03% to $0.26. The company's market cap stands at $17.7 million.

Losers

  • Revelation Biosciences (NASDAQ:REVBU) shares fell 18.6% to $0.3 during Tuesday's after-market session.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) stock declined by 9.81% to $0.6. The company's market cap stands at $11.2 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) shares decreased by 8.46% to $0.54. The market value of their outstanding shares is at $5.9 million.
  • Sesen Bio (NASDAQ:SESN) shares declined by 8.1% to $0.47. The market value of their outstanding shares is at $93.2 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares decreased by 6.6% to $0.85. The market value of their outstanding shares is at $18.4 million.
  • Viking Therapeutics (NASDAQ:VKTX) stock fell 5.11% to $2.79. The market value of their outstanding shares is at $213.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADMP AGTC BVXV HTGM KPRX NVIV OPGN REVBU SESN UPC VKTX WORX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist